Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
How to get BPC-157 + TB-500 online
ARA-290 received FDA Orphan Drug Designation for this indication TRPV1-mediated pain models ARA-290 demonstrated specific inhibition of TRPV1 channel activity, relieving capsaicin-induced mechanical hypersensitivity in pre-clinical nociceptor models Complex Regional Pain Syndrome (CRPS) investigational studies have examined ARA-290 in CRPS models due to its dual anti-inflammatory and nociceptor-targeting mechanism Chronic neuropathic pain multiple studies confirm ARA-290 reduces neuroinflammation in the spinal cord by suppressing TNF-, IL-1, and other pro-inflammatory cytokines that maintain chronic pain states Neuroprotection and CNS Research: Cerebral ischaemia/stroke models Wang et al
Eligibility for compounded tirzepatide with B12 for weight loss is determined by a licensed healthcare provider
Acetyl Tetrapeptide-5 for Under-Eye Bags This innovative peptide is specifically designed to combat the appearance of under-eye bags by addressing multiple underlying causes: Reducing fluid accumulation, which is a major contributor to the formation of under-eye bags, by improving the skins natural drainage ability
It can influence pro-inflammatory molecules like interleukin-6 (IL-6) and TNF-alpha, which are linked to prolonged inflammation in injury models
US$ 27.26
US$ 22.27
US$ 20.96
US$ 23.40
